Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies
- 1 September 2016
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 165, 132-152
Abstract
No abstract availableKeywords
This publication has 359 references indexed in Scilit:
- Optic Vesicle-like Structures Derived from Human Pluripotent Stem Cells Facilitate a Customized Approach to Retinal Disease TreatmentStem Cells, 2011
- The assessment of non-feminizing estrogens for use in neuroprotectionBrain Research, 2011
- Mitochondrial mechanisms of estrogen neuroprotectionBiochimica et Biophysica Acta (BBA) - General Subjects, 2010
- Leber Hereditary Optic Neuropathy Gene Therapy Clinical Trial RecruitmentArchives of Ophthalmology (1950), 2010
- No Evidence of Association of Heterozygous NTF4 Mutations in Patients with Primary Open-Angle GlaucomaThe American Journal of Human Genetics, 2010
- Heterozygous NTF4 Mutations Impairing Neurotrophin-4 Signaling in Patients with Primary Open-Angle GlaucomaThe American Journal of Human Genetics, 2009
- The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodiesBrain Research Reviews, 2009
- Estrogenic control of mitochondrial function and biogenesisJournal of Cellular Biochemistry, 2008
- Optimized Allotopic Expression of the Human Mitochondrial ND4 Prevents Blindness in a Rat Model of Mitochondrial DysfunctionThe American Journal of Human Genetics, 2008
- Effects of memantine on mitochondrial functionBiochemical Pharmacology, 2008